correspondent-denominate
Living With Myelofibrosis

Mayo Clinic

One Thousand Patients With Primary Myelofibrosis: the Mayo Clinic Experience

Dr. Ayalew Tefferi, Consultant in the Department of Hematology at Mayo Clinic in Rochester, MN, discusses his article appearing in the January 2012 issue of Mayo Clinic Proceedings describing the Mayo Clinic experience with 1000 patients who have primary myelofibrosis and providing context for the design and interpretation of clinical… Continue reading

Myelofibrosis and Bone Marrow Transplant – Mayo Clinic

Ruben Mesa, MD and Veena Fauble, MD, Mayo Clinic hematologists, discuss bone marrow transplant as a treatment option for patients diagnosed with myelofibrosis.

A quote for you...


Powered By Optimism Quotes

Survival Data for Patients Younger Than 60 With Primary Myleofibrosis–Mayo Clinic Proceedings

Dr. Ayalew Tefferi, Professor of Hematology and Medicine at Mayo Clinic in Rochester, MN, discusses the findings of the largest ever study with the most mature data currently available of patients with primary myelofibrosis younger than 60 years. These 176 patients were followed up for a median of 8 years… Continue reading

Myelofibrosis Study

Two janus kinase (JAK) inhibitors are substantially improving treatment of myelofibrosis in patients, say Mayo Clinic researchers who are presenting results of several clinical trials at the 52nd annual meeting of the American Society of Hematology (ASH) Dec. 4–7 in Orlando. Their findings suggest that both drugs, CYT387 and TG101348,… Continue reading

Translate This Page
Who's Online
2 visitors online now
Follow Us

Copyright © 2011. All Rights Reserved.